Skip to main content
Parislegal
Science

New Technology from UCLA Aims to Enhance Measurement of Drug Binding to Proteins

An international team led by UCLA has introduced a novel technology that may improve the understanding of how drugs and small molecules interact with proteins, potentially aiding in drug development.

Editorial Staff
1 min read
Updated 8 days ago
Share: X LinkedIn

A research collaboration led by UCLA has announced a significant advancement in the measurement of how small molecules, including various drugs, bind to proteins.

This new technology is designed to complement an existing laboratory method known as pho, potentially providing researchers with enhanced tools for studying drug interactions.

Understanding these binding processes could be crucial for drug development, as it may help identify off-target effects that can complicate treatment outcomes.